Merieux Equity et al. in series-A round for Cell-Easy

The company plans to use the funding to expand its manufacturing platform, scale up its team, strengthen its commercial presence and accelerate its expansion in France and internationally.

Merieux invested in the company via OMX Europe Venture Fund, a €90m vehicle launched in May 2020.

Previous funding
Cell-Easy raised €1m in funding from various investors in December 2019.

Company
Established in 2015 and based in Toulouse, Cell-Easy is a developer of ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development.

Cell-Easy has several contracts with biotechnology and pharmaceutical companies, as well as clinical research centres in hospitals and universities.

People
Cell-Easy – Pierre Monsan (CEO); Guillaume Costecalde (founder, chair).
Merieux Equity Partners – Yoann Bonnamour (associate).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Healthcare
• Venture
• France